Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Plasmatic Extracellular Vesicles in Acute Graft-Versus-Host Disease after Haplo-Identical Allografting with Post-Transplant Cyclophosphamide

Giuseppe Lia, PhD, Clara Di Vito, PhD, Marta Tapparo, PhD, Stefania Bruno, Elisa Zaghi, Michela Calvi, Lucia Brunello, Jacopo Mariotti, MD, Lorenzo Comba, Luisa Giaccone, Martina Fascì, Mario Boccadoro, Andrea Evangelista, MSc, Luca Castagna, MD, Giovanni Camussi, Domenico Mavilio, Benedetto Bruno, MD

Blood (2019) 134 (Supplement_1): 598.

https://doi.org/10.1182/blood-2019-126521

Published: 2019

Journal Articles

Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate

Armando Santoro, MD, Luca Castagna, MD, Massimo Magagnoli, MD, Stefania Bramanti, MD, Jacopo Mariotti, MD, Rita Mazza, MD, Lucia Morello, MD, Francesca Ricci, MD, Barbara Sarina, MD, Chiara De Philippis, MD, Simona Sica, MD, Marcello Rodari, MD, Martina Sollini, MD, Margarita Kirienko, MD, Laura Giordano, Arturo Chiti, MD, Paolo Corradini, MD, Carmelo Carlo-Stella, MD

Blood (2018) 132 (Supplement 1): 2185.

https://doi.org/10.1182/blood-2018-99-118127

Published: 2018

Journal Articles

Haploidentical Allogeneic Hematopoietic Cell Transplantation for Mantle Cell Lymphoma Using Post-Transplantation Cyclophosphamide Graft-Versus-Host Disease Prophylaxis

Chiara De Philippis, MD, Jacopo Mariotti, MD, Reda Bouabdallah, MD, Raynier Devillier, Stefania Bramanti, MD, Samia Harbi, MD, Sabine Furst, MD, Faezeh Legrand, MD, Barbara Sarina, MD, Carmelo Carlo-Stella, MD, Armando Santoro, MD, Didier Blaise, Luca Castagna

Blood (2018) 132 (Supplement 1): 5748.

https://doi.org/10.1182/blood-2018-99-117005

Published: 2018

Journal Articles

High Cure Rates of the Short-Term GITIL Chemotherapy Programme for Adult Patients with Burkitt Lymphoma

Jacopo Mariotti, MD, Anna Guidetti, MD, Michele Magni, MD, Paola Matteucci, MD, Liliana Devizzi, MD, Andrés J.M. Ferreri, Paolo Corradini, MD, Anna Dodero, MD, Amalia De Renzo, Alessandro Massimo Gianni, MD, Massimo Di Nicola, MD

Blood (2014) 124 (21): 1734.

https://doi.org/10.1182/blood.V124.21.1734.1734

Published: 2014

Journal Articles

Pharmacologic Inhibition of JAK1/JAK2 Signaling Protects from Acute GvHD While Preserving Gvt in Mice

Cristiana Carniti, Silvia Gimondi, Antonio Vendramin, Camilla Recordati, DVM, PhD Dipl. ECVP, Davide Confalonieri, Anisa Bermema, Paolo Corradini, MD, Jacopo Mariotti, MD

Blood (2014) 124 (21): 1107.

https://doi.org/10.1182/blood.V124.21.1107.1107

Published: 2014

Journal Articles

Inhibition of Jak1/Jak2 Is More Effective Than Inhibition of Jak3 in Protecting Mice From Acute Graft-Versus-Host Disease (aGvHD) by Significantly Decreasing Alloreactive CD4+ T-Cells.

Cristiana Carniti, PhD, Silvia Gimondi, Raffaella Vaccaroli, Antonio Vendramin, PhD, Anisa Bermema, Enrico Radaelli, DVM, PhD, Jacopo Mariotti, MD, Paolo Corradini, MD

Blood (2012) 120 (21): 2997.

https://doi.org/10.1182/blood.V120.21.2997.2997

Published: 2012

Journal Articles

G-CSF Stem Cell Mobilization Is Protective Against Acute Graft-Versus-Host Disease (aGvHD) by Increasing Myeloid-Derived Suppressor Cell (MDSC) Frequencies

Cristiana Carniti, PhD, Antonio Vendramin, PhD, Silvia Gimondi, Anisa Bermema, Fabiana Riva, Jacopo Mariotti, MD, Paolo Corradini, MD

Blood (2012) 120 (21): 1898.

https://doi.org/10.1182/blood.V120.21.1898.1898

Published: 2012

Journal Articles

Noninvasive Prediction of Acute Graft-Verus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation by Circulating miRNA Profiling

Cristiana Carniti, PhD, Silvia Gimondi, Davide Lucini, Jacopo Mariotti, MD, Anisa Bermema, Antonio Vendramin, Mara Morelli, MD, Chiara Formica, Paolo Corradini, MD

Blood (2011) 118 (21): 311.

https://doi.org/10.1182/blood.V118.21.311.311

Published: 2011

Journal Articles

T-Rapa Cell Clinical Products Contain a Balance of Minimally Differentiated Th2/Th1 Effector Cells Depleted of Treg Cells

Miriam E. Mossoba, PhD, Jacopo Mariotti, MD, Xiao-Yi Yan, Anu Gangopadhyay, Mathew Winterton, Marianna Sabatino, MD, Hanh Khuu, MD, Vicki Fellowes, Frances T. Hakim, PhD, David Stroncek, MD, Susan Leitman, MD, Bruce L Levine, PhD, Carl H. June, MD, Daniel H Fowler, MD

Blood (2010) 116 (21): 352.

https://doi.org/10.1182/blood.V116.21.352.352

Published: 2010

Journal Articles

Ex Vivo Rapamycin Generates Th2 Cells with Enhanced Mitochondrial Function and Reduced Apoptosis Via Intrinsic and Extrinsic Pathways.

Jacopo Mariotti, MD, Jason Foley, Elaine Wong, Babak Behbahani, Daniel H. Fowler, MD

Blood (2006) 108 (11): 1736.

https://doi.org/10.1182/blood.V108.11.1736.1736

Published: 2006

Journal Articles

Pilot Clinical Trial of Adoptive Immunotherapy with Chimeric, Co-Stimulated Tumor-Infiltrating Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation.

Nancy M. Hardy, MD, Vicki Fellowes, Jacopo Mariotti, MD, Charles Carter, Carl June4, MD, Bruce L. Levine4, PhD, Frances Hakim, PhD, Robert Vonderheide4, MD, DPhil, Ronald Gress, MD, Elizabeth J. Read, MD, Daniel Fowler, MD, Michael R. Bishop, MD

Blood (2005) 106 (11): 5407.

https://doi.org/10.1182/blood.V106.11.5407.5407

Published: 2005

Journal Articles

Rapamycin Generated Murine Th2/Tc2 Cells Potently Abrogate Fully MHC-Mismatched Hematopoietic Stem Cell (HSC) Graft Rejection.

Jacopo Mariotti, MD, Jason Foley, Todd Borenstein, Soo Han, Daniel H. Fowler, MD

Blood (2005) 106 (11): 192.

https://doi.org/10.1182/blood.V106.11.192.192

Published: 2005

NARROW

Plasmatic Extracellular Vesicles in Acute Graft-Versus-Host Disease after Haplo-Identical Allografting with Post-Transplant Cyclophosphamide

Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate

Haploidentical Allogeneic Hematopoietic Cell Transplantation for Mantle Cell Lymphoma Using Post-Transplantation Cyclophosphamide Graft-Versus-Host Disease Prophylaxis

High Cure Rates of the Short-Term GITIL Chemotherapy Programme for Adult Patients with Burkitt Lymphoma

Pharmacologic Inhibition of JAK1/JAK2 Signaling Protects from Acute GvHD While Preserving Gvt in Mice

Inhibition of Jak1/Jak2 Is More Effective Than Inhibition of Jak3 in Protecting Mice From Acute Graft-Versus-Host Disease (aGvHD) by Significantly Decreasing Alloreactive CD4+ T-Cells.

G-CSF Stem Cell Mobilization Is Protective Against Acute Graft-Versus-Host Disease (aGvHD) by Increasing Myeloid-Derived Suppressor Cell (MDSC) Frequencies

Noninvasive Prediction of Acute Graft-Verus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation by Circulating miRNA Profiling

T-Rapa Cell Clinical Products Contain a Balance of Minimally Differentiated Th2/Th1 Effector Cells Depleted of Treg Cells

Ex Vivo Rapamycin Generates Th2 Cells with Enhanced Mitochondrial Function and Reduced Apoptosis Via Intrinsic and Extrinsic Pathways.

Pilot Clinical Trial of Adoptive Immunotherapy with Chimeric, Co-Stimulated Tumor-Infiltrating Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation.

Rapamycin Generated Murine Th2/Tc2 Cells Potently Abrogate Fully MHC-Mismatched Hematopoietic Stem Cell (HSC) Graft Rejection.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only